| 2015 | | Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea. | 정윤석 |
| 2012 | | Clinical, biochemical, and genetic analysis of two korean patients with trichorhinophalangeal syndrome type I and growth hormone deficiency | 김옥화, 손영배 |
| 2015 | | Comparative Study of Growth Hormone Treatment in Children with Idiopathic Short Stature and Growth Hormone Deficiency. | 권은별, 이해상, 황진순 |
| 2020 | | Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology | 최용준 |
| 2023 | | Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty | 심영석, 이해상, 황진순 |
| 2018 | | Effect of Growth Hormone Therapy on Height Velocity in Korean Children with Idiopathic Short Stature: A Phase III Randomised Controlled Trial | 황진순 |
| 2019 | | Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial | 손영배 |
| 2013 | | Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency. | 이해상, 황진순 |
| 2014 | | Efficacy and safety of sustained-release recombinant human growth hormone in Korean adults with growth hormone deficiency. | 정윤석 |
| 2021 | | Efficacy and safety of the recombinant human growth hormone in short children born small for gestational age: A randomized, multicentre, comparative phase III trial | 황진순 |
| 2021 | | Gene polymorphisms in leptin and its receptor and the response to growth hormone treatment in patients with idiopathic growth hormone deficiency | 심영석 |
| 2013 | | Genetic investigation of patients with undetectable peaks of growth hormone after two provocation tests. | 손영배 |
| 2024 | | Healthcare professionals’ perspectives towards the digitalisation of paediatric growth hormone therapies: expert panels in Italy and Korea | 이해상 |
| 2022 | | Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment | 황진순 |
| 2010 | | Influence of parental origin of the X chromosome on physical phenotypes and GH responsiveness of patients with Turner syndrome. | 고정민 |
| 2018 | | Long-acting FC-fusion rhGH (GX-H9) shows potential for up to twice-monthly administration in GH-deficient adults | 정윤석 |
| 2022 | | Long-term effectiveness of growth hormone therapy in children born small for gestational age: An analysis of LG growth study data | 이해상, 황진순 |
| 2018 | | Once-Weekly Administration of Sustained-Release Growth Hormone in Korean Prepubertal Children with Idiopathic Short Stature: A Randomized, Controlled Phase II Study | 이해상, 황진순 |
| 2015 | | Pharmacokinetics, Pharmacodynamics, and Efficacy of a Novel Long-Acting Human Growth Hormone: Fc Fusion Protein. | 손영배 |
| 2018 | | Recombinant growth hormone therapy for prepubertal children with idiopathic short stature in Korea: a phase III randomized trial | 황진순 |
| 2012 | | Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation | 황진순 |
| 2011 | | Sustained-release recombinant human growth hormone improves body composition and quality of life in adults with somatopause. | 정윤석 |
| 2010 | | The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome. | 고정민 |
| 2014 | | The effect of growth hormone treatment on height in children with idiopathic short stature. | 심영석, 이해상, 정활림, 황진순 |
